Creotech Quantum S.A.
Company Overview
Creotech Quantum S.A. is a Polish deep-tech company focused on advanced electronics and complete technology systems for quantum technologies and demanding scientific and industrial applications. The company develops quantum key distribution systems, control and measurement systems for quantum and laboratory infrastructure, White Rabbit precise time-synchronization systems, MTCA systems, Sinara ecosystem solutions, and advanced cameras for astronomy and research laboratories.
Business Segments
- Quantum Key Distribution (QKD) Systems – secure communication systems for terrestrial and space-related applications
- Sinara Ecosystem / ARTIQ – control systems for quantum processors and laboratory infrastructure
- MTCA Systems – modular control and measurement electronics for scientific and industrial applications
- White Rabbit – precise time-synchronization systems for applications requiring ultra-accurate timing
- Advanced Cameras with sCMOS Sensors – cameras for astronomy, laboratories, and advanced research applications
Key Drivers
- European and national funding for quantum technologies and secure communication infrastructure
- Growing demand for quantum-safe communication in government, defense, telecom, finance, and critical infrastructure
- Commercialization of QKD systems and industrial-grade time-synchronization solutions
- Participation in European initiatives such as Quantum Flagship and EuroQCI
- Expansion of relationships with scientific and industrial partners such as CERN, ESA, DESY, and GSI
Key Risks
- Early-stage commercialization risk in quantum technologies
- Dependence on public grants, European programs, and research-driven demand
- Long and uncertain sales cycles in scientific, government, defense, and critical infrastructure markets
- Technology execution risk in QKD, quantum-control electronics, and advanced timing systems
- Competition from larger international quantum, photonics, telecom, and scientific-instrumentation companies
What to Watch
- New contracts for QKD, White Rabbit, MTCA, Sinara, and scientific camera systems
- Progress in EuroQCI, Quantum Flagship, and other European quantum infrastructure programs
- Evidence of recurring or repeat commercial orders beyond R&D projects
- Grant funding, strategic partnerships, and customer diversification
- Revenue growth and margin profile after the spin-off as a standalone public company
Foundational Analysis
Business Model
Creotech Quantum generates revenue from the design, manufacture, integration, and delivery of advanced electronics and complete technology systems for quantum, scientific, industrial, and critical-infrastructure applications. The model is likely project-driven at the current stage, with potential future scalability from repeatable product lines such as QKD systems, White Rabbit timing equipment, MTCA systems, Sinara-based control electronics, and advanced scientific cameras.
Competitive Positioning
Specialized European deep-tech company with credibility from projects and relationships in the scientific and institutional ecosystem. Its position is supported by experience with CERN, ESA, DESY, GSI, Quantum Flagship, and EuroQCI-related initiatives. The key challenge is converting technical credibility and R&D references into scalable commercial revenue.
Economics & Capital Allocation
Deep-tech hardware and systems business with meaningful engineering intensity, R&D requirements, and project execution risk. Near-term profitability may depend on contract mix, grant funding, and the ability to move from bespoke projects toward repeatable product sales. Financial metrics should be validated once standalone post-spin-off reporting history becomes available.
Capital allocation is expected to focus on R&D, product commercialization, engineering capacity, certifications, and access to grant-funded programs. As a newly separated company, external financing and grant eligibility may be important for accelerating development and commercialization.
Long-term Risks
Long-term risks include slow adoption of quantum technologies, delays in public quantum infrastructure programs, loss of technological relevance, inability to scale beyond research customers, dependence on specialized engineering talent, and competitive pressure from larger international quantum and instrumentation players.
What Would Break the Thesis
- Failure to commercialize QKD or quantum-control systems beyond R&D projects
- Material reduction or delay in European quantum infrastructure funding
- Loss of key scientific or institutional customers and partners
- Persistent inability to generate standalone revenue growth after the spin-off
Contracts Intelligence
No contract data available for this company.
View News InsteadFinancial Performance
No financial data available for this company.
Please try again later or contact support if the issue persists.
Recent News & Developments
Sentiment Analysis (Last 6 Months)
| Positive | 67% |
| Neutral | 33% |
| Negative | 0% |
Based on 3 articles
Creotech Quantum S.A. Plans Capital Raise to Accelerate R&D and Market Expansion
Warsaw-based Creotech Quantum S.A., a leader in quantum technology solutions, has announced plans to raise approximately PLN 55-60 million in capital over the next two years to support its ambitious growth strategy. The company is considering a share issuance by mid-2026 to secure the necessary funding. Additionally, Creotech Quantum intends to continue leveraging national and international grant programs, including projects commissioned by the European Commission and the European Space Agency, to co-finance its research and development (R&D) efforts.
The company plans to allocate 50%-65% of the raised funds to R&D and organizational expansion. Key initiatives include:
- Development of next-generation Quantum Key Distribution (QKD) systems for terrestrial infrastructures.
- Creation of single-photon detectors and QKD receivers for optical ground stations (OGS) to enable secure quantum communication from orbit.
- Advancement of new-generation cameras for space safety systems.
- Development of next-generation electronics for quantum processor control.
- Enhancement of operational structures, including ISO/NIS2 compliance, security infrastructure, and engineering capabilities.
The remaining funds will focus on business development and commercialization, including:
- Market introduction of the company's first QKD system and other QKD-related products.
- Production of advanced astronomical and quantum cameras for demonstrations and pilot testing.
- Expansion of the business division, including sales and marketing teams, and participation in international trade fairs and conferences.
- Stocking proprietary products to ensure quick order fulfillment and cost optimization through larger production batches.
Creotech Quantum also hinted at the possibility of achieving its strategic goals through acquisitions or partial acquisitions.
Relevance: This announcement aligns with Creotech Quantum S.A.'s mission to advance foundational technologies for the quantum economy, including secure quantum communication and cutting-edge quantum infrastructure solutions.
Allianz Polska Becomes Shareholder in Creotech Quantum S.A. Following Corporate Restructuring
Warsaw-based Creotech Quantum S.A. announced today that Allianz Polska Open Pension Fund (Allianz OFE), managed by Powszechne Towarzystwo Emerytalne Allianz Polska S.A., has acquired a 5.41% stake in the company. This development follows the allocation of 235,684 shares to Allianz OFE as part of a corporate restructuring, which involved the spin-off of Creotech Quantum S.A. from its parent company, Creotech Instruments S.A., on a 1:1 basis. The transaction was finalized on April 16, 2026, and officially reported on April 17, 2026.
Creotech Quantum S.A. specializes in cutting-edge engineering solutions for the quantum economy, including quantum processor control systems, secure quantum communication technologies, and advanced measurement instruments. The acquisition by Allianz Polska highlights growing investor confidence in the company’s innovative contributions to the quantum technology sector.
Relevance: This development underscores Creotech Quantum S.A.'s strategic importance in the quantum economy and its ability to attract institutional investors, further solidifying its position as a key player in the industry.
Creotech Quantum S.A. Announces 2026 Financial Reporting Schedule
Creotech Quantum S.A., headquartered in Warsaw, has officially disclosed the schedule for its periodic financial reports for 2026. The company plans to release its annual report for 2025 on April 28, 2026, followed by the semi-annual report for the first half of 2026 on September 30, 2026. Additionally, quarterly reports are set for publication on June 1, 2026 (Q1 2026) and November 30, 2026 (Q3 2026). Any changes to these dates will be communicated through current reports, as per regulatory requirements.
The announcement aligns with Creotech Quantum S.A.'s commitment to transparency and compliance with financial reporting standards, ensuring stakeholders remain informed about the company's performance and strategic direction.
Relevance: This announcement underscores Creotech Quantum S.A.'s dedication to maintaining regulatory compliance and fostering trust among investors, which is crucial for its growth in the competitive quantum technology sector.
2026 EPS Estimates
- Delayed quantum market adoption, weak conversion of R&D projects into commercial contracts, dependence on grants, cost overruns, or stronger-than-expected competition from larger international players
- No reliable standalone EPS estimate provided
- Base case depends on gradual commercialization of QKD, White Rabbit, MTCA, Sinara, and advanced camera systems, supported by European quantum funding and institutional demand
- Successful commercialization of QKD and timing systems, strong participation in European quantum infrastructure programs, repeat orders from scientific and industrial customers, and improved scalability of standardized product lines
Note: EPS estimates are for informational purposes only and represent our analytical framework, not investment recommendations. These financial results estimates are based on stated assumptions and may change as new information becomes available.
Key Metrics
Company-specific performance indicators tailored to Creotech Quantum S.A.'s business model.
Company not found.
Please try again later or contact support if the issue persists.
Data Source: Key metrics are extracted from company disclosures, periodic reports, and management commentary.
Periodic Report Publication Calendar
No report publication schedule available yet for this company.